Coverart for item
The Resource Cancer pharmacology and pharmacotherapy review : study guide for oncology boards and MOC exams, Francis P. Worden, MD, RPh, Professor, Division of Hematology/Oncology, Department of Internal Medicine, University of Michigan Health System, Ann Arbor, Michigan, Anthony J. Perissinotti, PharmD, BCOP, Clinical Pharmacist Specialist, Inpatient Hematology, Department of Pharmacy, University of Michigan Health Services, Ann Arbor, Michigan, Bernard L .Marini, PharmD, Clinical Pharmacist Specialist, Inpatient Hematology, Department of Pharmacy, University of Michigan Health Services, Ann Arbor, Michigan, (electronic resource)

Cancer pharmacology and pharmacotherapy review : study guide for oncology boards and MOC exams, Francis P. Worden, MD, RPh, Professor, Division of Hematology/Oncology, Department of Internal Medicine, University of Michigan Health System, Ann Arbor, Michigan, Anthony J. Perissinotti, PharmD, BCOP, Clinical Pharmacist Specialist, Inpatient Hematology, Department of Pharmacy, University of Michigan Health Services, Ann Arbor, Michigan, Bernard L .Marini, PharmD, Clinical Pharmacist Specialist, Inpatient Hematology, Department of Pharmacy, University of Michigan Health Services, Ann Arbor, Michigan, (electronic resource)

Label
Cancer pharmacology and pharmacotherapy review : study guide for oncology boards and MOC exams
Title
Cancer pharmacology and pharmacotherapy review
Title remainder
study guide for oncology boards and MOC exams
Statement of responsibility
Francis P. Worden, MD, RPh, Professor, Division of Hematology/Oncology, Department of Internal Medicine, University of Michigan Health System, Ann Arbor, Michigan, Anthony J. Perissinotti, PharmD, BCOP, Clinical Pharmacist Specialist, Inpatient Hematology, Department of Pharmacy, University of Michigan Health Services, Ann Arbor, Michigan, Bernard L .Marini, PharmD, Clinical Pharmacist Specialist, Inpatient Hematology, Department of Pharmacy, University of Michigan Health Services, Ann Arbor, Michigan
Creator
Contributor
Subject
Genre
Language
eng
Cataloging source
DNLM/DLC
http://library.link/vocab/creatorName
Worden, Francis P
Dewey number
615.7/98076
LC call number
RS431.A64
LC item number
W67 2016
NLM call number
QV 18.2
http://library.link/vocab/relatedWorkOrContributorName
  • Perissinotti, Anthony J
  • Marini, Bernard
http://library.link/vocab/subjectName
  • Antineoplastic Agents
  • Neoplasms
Label
Cancer pharmacology and pharmacotherapy review : study guide for oncology boards and MOC exams, Francis P. Worden, MD, RPh, Professor, Division of Hematology/Oncology, Department of Internal Medicine, University of Michigan Health System, Ann Arbor, Michigan, Anthony J. Perissinotti, PharmD, BCOP, Clinical Pharmacist Specialist, Inpatient Hematology, Department of Pharmacy, University of Michigan Health Services, Ann Arbor, Michigan, Bernard L .Marini, PharmD, Clinical Pharmacist Specialist, Inpatient Hematology, Department of Pharmacy, University of Michigan Health Services, Ann Arbor, Michigan, (electronic resource)
Instantiates
Publication
Note
Includes index
Contents
  • Microtubule inhibitors -- Alkylating agents -- Enzyme inhibitors : topoisomerase I inhibitors -- Enzyme inhibitors : topoisomerase II inhibitors -- Antimetabolites -- Monoclonal antibodies -- VEGF trap -- Tyrosine kinase inhibitors -- Anti-androgen therapies -- Mammalian target of rapamycin (MTOR) inhibitors -- Histone deacetylase (HDAC) inhibitors -- Hypomethylating agents -- Proteasome inhibitors -- Immunomodulatory agents -- L-asparaginase enzymes -- Promyelocytic leukemia gene retinoic acid receptor-alpha (PMI-RARA)translocation inhibitors -- Sipuleucel-T(Provenge®) -- Omacetaxine (Synribo®) -- Estramustine (Emcyt®)
  • Microtubule inhibitors -- Alkylating agents -- Enzyme inhibitors : topoisomerase I inhibitors -- Enzyme inhibitors : topoisomerase II inhibitors -- Antimetabolites -- Monoclonal antibodies -- VEGF trap -- Tyrosine kinase inhibitors -- Anti-androgen therapies -- Mammalian target of rapamycin (MTOR) inhibitors -- Histone deacetylase (HDAC) inhibitors -- Hypomethylating agents -- Proteasome inhibitors -- Immunomodulatory agents -- L-asparaginase enzymes -- Promyelocytic leukemia gene retinoic acid receptor-alpha (PMI-RARA)translocation inhibitors -- Sipuleucel-T(Provenge®) -- Omacetaxine (Synribo®) -- Estramustine (Emcyt®)
Control code
OCM1bookssj0001623706
Dimensions
cm.
Dimensions
unknown
Extent
xiv, 189 pages
Governing access note
License restrictions may limit access
Isbn
9781620700761
Lccn
2015045238
Other physical details
illustrations
Specific material designation
remote
System control number
(WaSeSS)ssj0001623706
Label
Cancer pharmacology and pharmacotherapy review : study guide for oncology boards and MOC exams, Francis P. Worden, MD, RPh, Professor, Division of Hematology/Oncology, Department of Internal Medicine, University of Michigan Health System, Ann Arbor, Michigan, Anthony J. Perissinotti, PharmD, BCOP, Clinical Pharmacist Specialist, Inpatient Hematology, Department of Pharmacy, University of Michigan Health Services, Ann Arbor, Michigan, Bernard L .Marini, PharmD, Clinical Pharmacist Specialist, Inpatient Hematology, Department of Pharmacy, University of Michigan Health Services, Ann Arbor, Michigan, (electronic resource)
Publication
Note
Includes index
Contents
  • Microtubule inhibitors -- Alkylating agents -- Enzyme inhibitors : topoisomerase I inhibitors -- Enzyme inhibitors : topoisomerase II inhibitors -- Antimetabolites -- Monoclonal antibodies -- VEGF trap -- Tyrosine kinase inhibitors -- Anti-androgen therapies -- Mammalian target of rapamycin (MTOR) inhibitors -- Histone deacetylase (HDAC) inhibitors -- Hypomethylating agents -- Proteasome inhibitors -- Immunomodulatory agents -- L-asparaginase enzymes -- Promyelocytic leukemia gene retinoic acid receptor-alpha (PMI-RARA)translocation inhibitors -- Sipuleucel-T(Provenge®) -- Omacetaxine (Synribo®) -- Estramustine (Emcyt®)
  • Microtubule inhibitors -- Alkylating agents -- Enzyme inhibitors : topoisomerase I inhibitors -- Enzyme inhibitors : topoisomerase II inhibitors -- Antimetabolites -- Monoclonal antibodies -- VEGF trap -- Tyrosine kinase inhibitors -- Anti-androgen therapies -- Mammalian target of rapamycin (MTOR) inhibitors -- Histone deacetylase (HDAC) inhibitors -- Hypomethylating agents -- Proteasome inhibitors -- Immunomodulatory agents -- L-asparaginase enzymes -- Promyelocytic leukemia gene retinoic acid receptor-alpha (PMI-RARA)translocation inhibitors -- Sipuleucel-T(Provenge®) -- Omacetaxine (Synribo®) -- Estramustine (Emcyt®)
Control code
OCM1bookssj0001623706
Dimensions
cm.
Dimensions
unknown
Extent
xiv, 189 pages
Governing access note
License restrictions may limit access
Isbn
9781620700761
Lccn
2015045238
Other physical details
illustrations
Specific material designation
remote
System control number
(WaSeSS)ssj0001623706

Library Locations

    • Thomas Jefferson LibraryBorrow it
      1 University Blvd, St. Louis, MO, 63121, US
      38.710138 -90.311107
Processing Feedback ...